Cytoo

 

CYTOO SA

having its registered office at Minatec – BHT Bât. 52 – 7 parvis Louis Néel, FR – 38040 Grenoble cedex 9, France, represented by M. Luc SELIG, its General Manager.

RHU SMART program will lead to the development of a new SMA myotube model, based on CYTOO’s MyoScreen technology. CYTOO will use this model to establish R&D collaborations with Biotech and Pharma companies willing to test their therapeutic strategy for SMA treatment.